메뉴 건너뛰기




Volumn 49, Issue 3, 2011, Pages 443-445

ROMA or death: Advances in epithelial ovarian cancer diagnosis

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E4; CA 125 ANTIGEN; EPIDIDYMAL SECRETORY PROTEIN;

EID: 79952778180     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/CCLM.2011.073     Document Type: Review
Times cited : (13)

References (17)
  • 1
    • 33646560022 scopus 로고    scopus 로고
    • Systematic therapy for ovarian cancer: Current status and new treatments
    • Ozols RF. Systematic therapy for ovarian cancer: Current status and new treatments. Semin Oncol 2006;33:S3-11.
    • (2006) Semin Oncol , vol.33
    • Ozols, R.F.1
  • 3
    • 0024511529 scopus 로고
    • The CA 125 tumour-associated antigen: A review of the literature
    • Jacobs I, Bast RC Jr. The CA 125 tumor-associated antigen: A review of the literature. Hum Reprod 1989;4:1-12. (Pubitemid 19069900)
    • (1989) Human Reproduction , vol.4 , Issue.1 , pp. 1-12
    • Jacobs, I.1    Bast Jr., R.C.2
  • 5
    • 35848962931 scopus 로고    scopus 로고
    • How to improve reliability and efficiency of research about molecular markers: roles of phases, guidelines, and study design
    • DOI 10.1016/j.jclinepi.2007.04.020, PII S0895435607002831
    • Ransohoff DF. How to improve reliability and efficiency of research about molecular markers: Roles of phases, guidelines, and study design. J Clin Epidemiol 2007;60:1205-19. (Pubitemid 350061148)
    • (2007) Journal of Clinical Epidemiology , vol.60 , Issue.12 , pp. 1205-1219
    • Ransohoff, D.F.1
  • 9
    • 49249084432 scopus 로고    scopus 로고
    • Use of yeast-secreted in vivo biotinylated recombinanat antibodies (biobodies) in beadbased ELISA
    • Scholler N, Lowe KA, Bergan LA. Use of yeast-secreted in vivo biotinylated recombinanat antibodies (biobodies) in beadbased ELISA. Clin Cancer Res 2008;14:2647-55.
    • (2008) Clin Cancer Res , vol.14 , pp. 2647-2655
    • Scholler, N.1    Lowe, K.A.2    Bergan, L.A.3
  • 12
    • 57649088474 scopus 로고    scopus 로고
    • A novel multiple marker bioassay utilizing HE4 and CA125 for the prediction of ovarian cancer in patients with a pelvic mass
    • Moore RG, McMeekin DS, Brown AK, DiSilvestro P, Miller MC, Allard WJ, et al. A novel multiple marker bioassay utilizing HE4 and CA125 for the prediction of ovarian cancer in patients with a pelvic mass. Gynecol Oncol 2009;112:40-6.
    • (2009) Gynecol Oncol , vol.112 , pp. 40-46
    • Moore, R.G.1    McMeekin, D.S.2    Brown, A.K.3    DiSilvestro, P.4    Miller, M.C.5    Allard, W.J.6
  • 13
    • 64949192073 scopus 로고    scopus 로고
    • Serum HE4 concentration differentiates malignant ovarian tumours from ovarian endometriotic cysts
    • Huhtinen K, Suvitie P, Hiissa J, Junnila J, Huvila J, Kujari H, et al. Serum HE4 concentration differentiates malignant ovarian tumours from ovarian endometriotic cysts. Br J Cancer 2009; 100:1315-9.
    • (2009) Br J Cancer , vol.100 , pp. 1315-1319
    • Huhtinen, K.1    Suvitie, P.2    Hiissa, J.3    Junnila, J.4    Huvila, J.5    Kujari, H.6
  • 14
    • 77956342398 scopus 로고    scopus 로고
    • Comparison of a novel multiple marker assay vs the Risk of Malignancy Index for the prediction of epithelial ovarian cancer in patients with a pelvic mass
    • Moore RG, Jabre-Raughley M, Brown AK, Robison KM, Miller MC, Allard WJ, et al. Comparison of a novel multiple marker assay vs the Risk of Malignancy Index for the prediction of epithelial ovarian cancer in patients with a pelvic mass. Am J Obstet Gynecol 2010;203:228.e1-5.
    • (2010) Am J Obstet Gynecol , vol.203
    • Moore, R.G.1    Jabre-Raughley, M.2    Brown, A.K.3    Robison, K.M.4    Miller, M.C.5    Allard, W.J.6
  • 15
    • 79952784426 scopus 로고    scopus 로고
    • The ROMA (Risk of Ovarian Malignancy Algorithm) for estimating the risk of epithelial ovarian cancer in women presenting with pelvic mass: Is it really useful?
    • Montagnana M, Danese E, Ruzzenente O, Bresciani V, Nuzzo T, Gelati G, et al. The ROMA (Risk of Ovarian Malignancy Algorithm) for estimating the risk of epithelial ovarian cancer in women presenting with pelvic mass: Is it really useful? Clin Chem Lab Med 2011;49:521-5.
    • (2011) Clin Chem Lab Med , vol.49 , pp. 521-525
    • Montagnana, M.1    Danese, E.2    Ruzzenente, O.3    Bresciani, V.4    Nuzzo, T.5    Gelati, G.6
  • 16
    • 79952801158 scopus 로고    scopus 로고
    • Evaluation of the accuracy of serum human epididymis protein 4 in combination with CA125 for detecting ovarian cancer: A prospective case-control study in a Korean population
    • Kim YM, Whang DH, Park J, Kim SH, Lee SW, Park HA, et al. Evaluation of the accuracy of serum human epididymis protein 4 in combination with CA125 for detecting ovarian cancer: A prospective case-control study in a Korean population. Clin Chem Lab Med 2011;49:527-34.
    • (2011) Clin Chem Lab Med , vol.49 , pp. 527-534
    • Kim, Y.M.1    Whang, D.H.2    Park, J.3    Kim, S.H.4    Lee, S.W.5    Park, H.A.6
  • 17
    • 7044233360 scopus 로고    scopus 로고
    • Should CA-125 response criteria be preferred to response evaluation criteria in solid tumors (RECIST) for prognostication during second-line chemotherapy of ovarian carcinoma?
    • DOI 10.1200/JCO.2004.10.028
    • Grolund B. Høgdall C, Hilden J, Engelholm SA, Høgdall EVS, Hansen HH. Should CA125 response criteria be preferred to response evaluation criteria in solid tumors (RECIST) for prognostication during second-line chemotherapy of ovarian carcinoma? J Clin Oncol 2004;22:4051-8. (Pubitemid 41199651)
    • (2004) Journal of Clinical Oncology , vol.22 , Issue.20 , pp. 4051-4058
    • Gronlund, B.1    Hogdall, C.2    Hilden, J.3    Engelholm, S.A.4    Hogdall, E.V.S.5    Hansen, H.H.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.